Juventas Therapeutic raises $13.5 million for clinical trials

Story excerpt provided by Crain’s Cleveland Business.

Written by Timothy Magaw.

Juventas Therapeutics, a Cleveland-based clinical-stage company developing regenerative therapies for treatment of cardiovascular diseases, has secured $13.5 million in financing to support future clinical studies.

Click here to read the complete article.

Originally published May 12, 2015.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: